Skip to main content

Publications

Sanders, DB, Wolfe, GI, Narayanaswami, P, and MGFA Task Force on MG Treatment Guidance, . "Developing treatment guidelines for myasthenia gravis." Annals of the New York Academy of Sciences 1412, no. 1 (January 2018): 95-101. (Review)

Full Text

Creed, JA, Son, J, Farjat, AE, and Swisher, CB. "Early withdrawal of non-anesthetic antiepileptic drugs after successful termination of nonconvulsive seizures and nonconvulsive status epilepticus." Seizure 54 (January 1, 2018): 45-50.

Full Text

Huang, S, Ge, X, Yu, J, Han, Z, Yin, Z, Li, Y, Chen, F, Wang, H, Zhang, J, and Lei, P. "Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons." FASEB journal : official publication of the Federation of American Societies for Experimental Biology 32, no. 1 (January 2018): 512-528.

Full Text

Weintraub, S, Carrillo, MC, Farias, ST, Goldberg, TE, Hendrix, JA, Jaeger, J, Knopman, DS, Langbaum, JB, Park, DC, Ropacki, MT, Sikkes, SAM, Welsh-Bohmer, KA, Bain, LJ, Brashear, R, Budur, K, Graf, A, Martenyi, F, Storck, MS, and Randolph, C. "Measuring cognition and function in the preclinical stage of Alzheimer's disease." Alzheimer's and Dementia: Translational Research and Clinical Interventions 4 (January 1, 2018): 64-75.

Full Text

Wen, PY, Drappatz, J, de Groot, J, Prados, MD, Reardon, DA, Schiff, D, Chamberlain, M, Mikkelsen, T, Desjardins, A, Holland, J, Ping, J, Weitzman, R, and Cloughesy, TF. "Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy." Neuro-oncology 20, no. 2 (January 2018): 249-258.

Full Text

Cloughesy, TF, Drappatz, J, de Groot, J, Prados, MD, Reardon, DA, Schiff, D, Chamberlain, M, Mikkelsen, T, Desjardins, A, Ping, J, Holland, J, Weitzman, R, and Wen, PY. "Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy." Neuro-oncology 20, no. 2 (January 2018): 259-267.

Full Text

Welty, S, Teng, Y, Liang, Z, Zhao, W, Sanders, LH, Greenamyre, JT, Rubio, ME, Thathiah, A, Kodali, R, Wetzel, R, Levine, AS, and Lan, L. "RAD52 is required for RNA-templated recombination repair in post-mitotic neurons." Journal of Biological Chemistry 293, no. 4 (January 1, 2018): 1353-1362.

Full Text

Sanders, DB, Guptill, JT, Aleš, KL, Hobson-Webb, LD, Jacobus, DP, Mahmood, R, Massey, JM, Pittman, MM, Prather, K, Raja, SM, Yow, E, and Juel, VC. "Reliability of the triple-timed up-and-go test." Muscle & nerve 57, no. 1 (January 2018): 136-139.

Full Text

van Schaik, IN, Bril, V, van Geloven, N, Hartung, H-P, Lewis, RA, Sobue, G, Lawo, J-P, Praus, M, Mielke, O, Durn, BL, Cornblath, DR, Merkies, ISJ, and PATH study group, . "Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial." The Lancet. Neurology 17, no. 1 (January 2018): 35-46.

Full Text

Nandedkar, SD, Sanders, DB, Hobson-Webb, LD, Billakota, S, Barkhaus, PE, and Stålberg, EV. "The extrapolated reference values procedure: Theory, algorithm, and results in patients and control subjects." Muscle & nerve 57, no. 1 (January 2018): 90-95.

Full Text

Pages